Correlation Between Evoke Pharma and ACELYRIN, INC

Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and ACELYRIN, INC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and ACELYRIN, INC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evoke Pharma and ACELYRIN, INC Common, you can compare the effects of market volatilities on Evoke Pharma and ACELYRIN, INC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of ACELYRIN, INC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and ACELYRIN, INC.

Diversification Opportunities for Evoke Pharma and ACELYRIN, INC

0.49

Correlation Coefficient

Evoke Pharma  ACELYRIN, INC

Very weak diversification

The 3 months correlation between Evoke and ACELYRIN, is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and ACELYRIN, INC Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACELYRIN, INC Common and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with ACELYRIN, INC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACELYRIN, INC Common has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and ACELYRIN, INC go up and down completely randomly.

Pair Corralation between Evoke Pharma and ACELYRIN, INC

Given the investment horizon of 90 days Evoke Pharma is expected to generate 0.74 times more return on investment than ACELYRIN, INC. However, Evoke Pharma is 1.35 times less risky than ACELYRIN, INC. It trades about -0.06 of its potential returns per unit of risk. ACELYRIN, INC Common is currently generating about -0.27 per unit of risk. If you would invest  538.00  in Evoke Pharma on October 11, 2024 and sell it today you would lose (97.00) from holding Evoke Pharma or give up 18.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Evoke Pharma  vs.  ACELYRIN, INC Common

Evoke Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Evoke Pharma is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

ACELYRIN, INC Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ACELYRIN, INC Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Evoke Pharma and ACELYRIN, INC

The main advantage of trading using opposite Evoke Pharma and ACELYRIN, INC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, ACELYRIN, INC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACELYRIN, INC will offset losses from the drop in ACELYRIN, INC's long position.

The idea behind Evoke Pharma and ACELYRIN, INC Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.